CATALOGO DEI PRODOTTI DELLA RICERCA

BUSTI, Fabiana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.281
NA - Nord America 2.966
AS - Asia 2.180
SA - Sud America 389
AF - Africa 59
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 5
Totale 8.886
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.904
RU - Federazione Russa 1.490
SG - Singapore 835
CN - Cina 691
GB - Regno Unito 565
BR - Brasile 316
SE - Svezia 222
HK - Hong Kong 218
DE - Germania 187
IT - Italia 185
VN - Vietnam 169
FR - Francia 162
IE - Irlanda 158
FI - Finlandia 136
KR - Corea 72
JP - Giappone 39
CA - Canada 35
NL - Olanda 33
UA - Ucraina 32
AR - Argentina 31
BE - Belgio 26
ID - Indonesia 24
IN - India 22
BD - Bangladesh 20
ZA - Sudafrica 18
TR - Turchia 17
ES - Italia 15
MX - Messico 15
PK - Pakistan 15
PL - Polonia 14
IQ - Iraq 13
AT - Austria 11
EC - Ecuador 10
IR - Iran 10
TG - Togo 10
EG - Egitto 9
VE - Venezuela 9
BJ - Benin 8
LT - Lituania 8
CL - Cile 7
AU - Australia 6
CZ - Repubblica Ceca 6
GR - Grecia 5
UZ - Uzbekistan 5
AL - Albania 4
BO - Bolivia 4
CH - Svizzera 4
DO - Repubblica Dominicana 4
KG - Kirghizistan 4
PE - Perù 4
AE - Emirati Arabi Uniti 3
BA - Bosnia-Erzegovina 3
CO - Colombia 3
DZ - Algeria 3
EU - Europa 3
HN - Honduras 3
HR - Croazia 3
JO - Giordania 3
OM - Oman 3
IL - Israele 2
KE - Kenya 2
KZ - Kazakistan 2
LV - Lettonia 2
MD - Moldavia 2
NP - Nepal 2
PH - Filippine 2
SA - Arabia Saudita 2
SN - Senegal 2
SR - Suriname 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BW - Botswana 1
BZ - Belize 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
EE - Estonia 1
GY - Guiana 1
IM - Isola di Man 1
JM - Giamaica 1
KW - Kuwait 1
LU - Lussemburgo 1
MA - Marocco 1
MU - Mauritius 1
MY - Malesia 1
MZ - Mozambico 1
NI - Nicaragua 1
NO - Norvegia 1
PT - Portogallo 1
PY - Paraguay 1
RS - Serbia 1
SC - Seychelles 1
TL - Timor Orientale 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UY - Uruguay 1
Totale 8.886
Salva come PNG Salva come JPEG
Città #
Moscow 505
Southend 463
Chandler 416
Singapore 412
Dallas 292
Ashburn 284
Jacksonville 227
Hong Kong 211
Ann Arbor 164
Dublin 156
Beijing 138
Woodbridge 130
New York 118
The Dalles 70
Houston 66
Wilmington 66
Los Angeles 64
Ho Chi Minh City 62
Lawrence 59
Princeton 59
Verona 53
Munich 52
Helsinki 46
Jinan 43
Boardman 40
Nanjing 40
São Paulo 35
Redondo Beach 34
Tokyo 34
Shenyang 27
Brussels 24
Buffalo 23
Santa Clara 21
Turku 21
Lancaster 20
Redmond 20
Falkenstein 19
Hanoi 19
London 19
Haikou 18
Seoul 18
Sindelfingen 18
Zhengzhou 18
Hebei 17
Tianjin 17
Columbus 16
Falls Church 16
Nanchang 16
Ningbo 16
Brooklyn 15
Poplar 15
Seattle 15
Changsha 13
Denver 13
Milan 13
Guangzhou 12
Jakarta 12
Lappeenranta 12
Nuremberg 12
San Francisco 12
Warsaw 12
Taiyuan 11
Taizhou 11
Toronto 11
Bologna 10
Lomé 10
Redwood City 10
Rio de Janeiro 10
Rome 10
Chicago 9
Dhaka 9
Hangzhou 9
Jiaxing 9
Montreal 9
Atlanta 8
Boston 8
Cotonou 8
Council Bluffs 8
Fuzhou 8
Johannesburg 8
Norwalk 8
Orem 8
Phoenix 8
Vienna 8
Amsterdam 7
Chennai 7
Lanzhou 7
Tehran 7
Villarbasse 7
Belo Horizonte 6
Fairfield 6
Frankfurt am Main 6
Haiphong 6
Stockholm 6
Alexandria 5
Ankara 5
Biên Hòa 5
Dong Ket 5
Nettuno 5
Porto Alegre 5
Totale 5.181
Salva come PNG Salva come JPEG
Nome #
A challenging case of abdominal pain associated to Helicobacter pylori infection 212
ALOX5AP gene variants and risk of coronary artery disease: an angiography-based study 209
Tarrgeted Exome Sequencing of 5 Hemochromatosis Genes in Iron Overloaded Patients by Next Generation Sequencing (NGS) Platform. 189
Increased serum hepcidin levels in subjects with the metabolic syndrome: a population study. 186
Identification of novel mutations in hemochromatosis genes by targeted next generation sequencing in Italian patients with unexplained iron overload 184
Genetic risk score from GWA studies is strongly associated with angiographically-defined coronary artery disease, but not with mortalilty in the setting of secondary prevention. 178
Altered iron parameters and hepcidin levels in a general population: lesson from the CHRIS study 176
Association of endogenous thrombin potential (ETP) with coronary artery disease. An angiography-based study 175
Identification of new BMP6 pro-peptide mutations in patients with iron overload 175
Additive effect of LRP8/APOER2 R952Q variant to APOE epsilon2/epsilon3/epsilon4 genotype in modulating apolipoprotein E concentration and the risk of myocardial infarction: a case-control study. 172
Clinical, pathological, and molecular correlates in ferroportin disease: a study of two novel mutations. 171
Association of endogenous thrombin potential (ETP) with coronary artery disease. an angiography-based study. 170
Altered paraoxonase expression in patients with genetic haemochromatosis. 169
Elevated D-dimer levels are associated with coronary artery disease and cardiovascular death in an angiographically-studied population 168
Targeted Next Generation Sequencing of the Five Hemochromatosis Genes in Italian Patients with Iron Overload and Non-Diagnostic First Level Genetic Test: A Pilot Study 166
Association of endogenous thrombin potential (ETP) with coronary artery disease. An angiography-based study. 165
Genomics of coronary artery disease and myocardial infarction. From Genome Wide Association Studies to the Next-Generation-Sequencing era 163
Paraoxonase-1 status in patients with hereditary hemochromatosis 157
Hepcidin suppression relative to iron status in patients with chronic Hepatitits C 152
Elevated D-dimer levels are associated with coronary artery disease and cardiovascular death in an angiographically-studied population. 145
Aceruloplasminemia: A Severe Neurodegenerative Disorder Deserving an Early Diagnosis 145
Genetic and Clinical Heterogeneity in Thirteen New Cases with Aceruloplasminemia. Atypical Anemia as a Clue for an Early Diagnosis 145
COBALAMIN DEFICIENCY IN THE ELDERLY 144
Serum Hepcidin Levels Correlate with Phenotypes of the Metabolic Syndrome At Population Level 142
CYBRD1 as a modifier gene that modulates iron phenotype in HFE p.c282y homozygous patients. 141
DISHphagia: An Unusual Cause of Dysphagia. J Clin Endocrinol Metab. 133
Anemia and Iron Deficiency in Cancer Patients: Role of Iron Replacement Therapy 133
Iron replacement therapy: entering the new era without misconceptions, but more research is needed 131
A Novel ALAS2 Missense Mutation in Two Brothers With Iron Overload and Associated Alterations in Serum Hepcidin/Erythroferrone Levels 129
Importance of Cardiopulmonary Exercise Testing amongst Subjects Recovering from COVID-19 129
An unusual case of inferior vena cava thrombosis: widening the differential diagnosis 128
Practical implications of the 2019 Nobel Prize in Physiology or Medicine: from molecular adaptation to hypoxia to novel anti-anemic drugs in the clinic 128
Genetic risk score from GWA studies is strongly associated with angiographically-defined coronary artery disease but not with mortality in the setting of secondary prevention 126
Modern iron replacement therapy: clinical and pathophysiological insights 125
Anemia and adverse outcomes in the elderly: a detrimental inflammatory loop? 125
Residual Lung Function Impairment Is Associated with Hyperventilation in Patients Recovered from Hospitalised COVID-19: A Cross-Sectional Study 125
HEPCIDIN SUPPRESSION IN BETA-THALASSEMIA CARRIERS WITH IRON OVERLOAD. Preliminary reports from an ongoing study. 124
Reduced serum hepcidin levels in patients with chronic hepatitis C 112
Iron replacement in inflammatory bowel disease: an evolving scenario 112
Red Blood Cell Morphologic Abnormalities in Patients Hospitalized for COVID-19 112
GNPAT rs11558492 is not a Major Modifier of Iron Status: Study of Italian Hemochromatosis Patients and Blood Donors 111
Anemia and iron deficiency in heart failure: extending evidences from chronic to acute setting 110
Identification of Early Biomarkers of Mortality in COVID-19 Hospitalized Patients: A LASSO-Based Cox and Logistic Approach 108
Iron metabolism in infections: Focus on COVID-19 106
Therapeutic oligonucleotides in cardiovascular and metabolic diseases: insights for the internist 97
Hyperferritinemia and diagnosis of type 1 Gaucher disease 97
Treatment options for anemia in the elderly 95
Is Ferroptosis a Key Component of the Process Leading to Multiorgan Damage in COVID-19? 92
Paraoxonase-1 status in patients with hereditary hemochromatosis. 91
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 90
Proprotein convertase 7 rs236918 is associated with liver fibrosis in Italian patients with HFE-related Hemochromatosis 90
Rare variants lowering the levels of coagulation factor X are protective against ischemic heart disease 89
Anemia in patients receiving anticancer treatments: focus on novel therapeutic approaches 86
Elevated plasma hepcidin concentrations are associated with an increased risk of mortality and nonfatal cardiovascular events in patients with type 2 diabetes: a prospective study 86
Systemic Inflammatory Response and Outcomes in Community-Acquired Pneumonia Patients Categorized According to the Smoking Habit or Presence of Chronic Obstructive Pulmonary Disease 86
Iron deficiency in the elderly population, revisited in the hepcidin era. 83
Replacing the suppressed hormone: toward a better treatment for iron overload in β-thalassemia major? 83
Impact of natural Neuromedin-B receptor variants on iron metabolism 81
A time course of hepcidin response to iron challenge in patients with HFE and TFR2 hemochromatosis 81
A case series of patients with β-thalassemia trait and iron overload: from multifactorial hepcidin suppression to treatment with mini-phlebotomies 79
Serum Erythroferrone in a Large General Population: Towards a Better Understanding of Connections Between Erythropoiesis and Iron Homeostasis 78
Targeted Next Generation Sequencing of the Five Hemochromatosis Genes in Italian patients with Iron Overload and Non-diagnostic First Level Genetic Test.A Pilot Study 78
The role of hypoxia and inflammation in the regulation of iron metabolism and erythropoiesis in COVID-19: The IRONCOVID study 76
Diagnosis and management of hereditary hemochromatosis: lifestyle modification, phlebotomy, and blood donation 72
Hemochromatosis classification: update and recommendations by the BIOIRON Society 70
Use of non-invasive respiratory supports in high-intensity internal medicine setting during the first two waves of the COVID-19 pandemic emergency in Italy: a multicenter, real-life experience 69
Iron distribution in different tissues of homozygous Mask (msk/msk) mice and the effects of oral iron treatments 67
ERFE regulation in sickle cell disease: complex but promising 66
Inflammation and iron homeostasis - what do blood tests mean? 63
Clonal hematopoiesis in cardiovascular aging: Insights from the verona heart study 62
The Role of Iron Staining in Myelodysplastic Syndromes: A Treasure Trove of Information 61
New Insights into the Role of Ferroptosis in Cardiovascular Diseases 60
Efficacy and Safety of Reparixin in Patients with Severe COVID-19 Pneumonia: A Phase 3, Randomized, Double-Blind Placebo-Controlled Study 54
Sparing unnecessary transfusions through patient blood management: time for application also in internal and emergency medicine 48
Manipulating hepcidin in polycythemia vera 42
Recent Advancements in Hematology: Knowledge, Methods and Dissemination-1 41
Recent Advancement of Hematology: Know, How to Do, Let Know 39
Recommendations for diagnosis, treatment, and prevention of iron deficiency and iron deficiency anemia 38
Totale 8.996
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.182
article - articoli 22.616
book - libri 0
conference - conferenze 7.182
curatela - curatele 0
other - altro 384
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 60.364
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021190 0 0 0 0 0 52 18 17 10 18 50 25
2021/2022530 15 159 3 63 20 23 7 28 20 17 50 125
2022/20231.143 67 132 94 198 100 254 22 87 139 4 24 22
2023/2024665 21 36 49 58 54 149 21 48 7 32 96 94
2024/20251.570 82 111 65 255 71 50 94 71 195 94 150 332
2025/20263.427 321 267 356 909 1.332 242 0 0 0 0 0 0
Totale 8.996